Every denied claim is a lot more than a billing setback: it is lost revenue and wasted staff time. For infusion pharmacy providers, each denial can disrupt cash flow and lead to a write-off. The reasons may often include missed eligibility checks, documentation gaps, prior authorization errors, or slow prior authorization that can delay the reimbursement process. In fact, recent reports have cited prior authorization errors as one of the biggest reasons behind infusion therapy claim denials.
The infusion chair is one of the most expensive pieces of real estate in a clinic. Every hour it sits occupied, it is supposed to generate revenue directly tied to CPT codes 96413 and 96415. However, a growing number of infusion centers are learning a hard lesson: a perfectly documented infusion leads to nothing if the prior authorization was incorrect, expired, or missing altogether.
That gap between “the patient received the infusion” and “the payer will pay for it” has widened enormously over the past few years. In fact, prior authorization denials rose to around 31% in 2026. Much of that growth is due to high-complexity specialty infusion and biologics, where payers have the most financial incentive to scrutinize every single step.
Here, in our blog, let us take a look at how prior authorization errors can collapse the entire infusion billing process and what steps can be taken to reduce these errors:
Why Are Infusion Claims Frequently Denied?
Infusion therapy claims have several different building components, all of which need to be matched. Providers should properly document drug administration, use the correct CPT and HCPCS codes, verify insurance coverage, and document all medical necessities before submitting a claim. There is no universal method for determining the acceptability of the claim. It may be accepted by some payers and denied by others based on policies. The avoidable denials can be prevented, and reimbursement can be kept on track through proper prior authorization and documentation.
Why Infusion Building Processes Are Error-prone
Infusion therapy sits at the intersection of medicine and billing. The clinical side is quite straightforward. A particular drug is infused for a particular duration, monitored by medical staff, and recorded with precise start and stop times. Those time stamps justify billing 96415 as an add-on code once the treatment passes the one-hour mark and the payer expects the extra time to reach at least 30 minutes past the hour before it counts as a billable unit. The financial side is where things start falling apart.
Because infusion drugs carry higher price tags, payers prioritize them for prior authorization. RCM Workshop’s infusion billing trends report notes that inaccurate or inadequate medical records remain the biggest reason for denials at infusion centers, and that prior authorization requirements are expanding further into specialty and biologics infusions this year. That signifies a properly coded claim can get denied for a reason that has nothing to do with the infusion itself.
Common Prior Authorization Errors That Lead to Denials
Here are a few common errors behind most of the damage caused during the infusion billing process.
Authorization Expiring Mid-treatment
Infusion therapies mostly occur in cycles over a longer span of time. If the original authorization covers only a particular number of sessions or a specific window of treatment and the prior auth request isn’t submitted on time, later sessions in the same course of treatment can be delivered with no valid prior authorization on file.
Outdated Payer Requirements Checklist
Payers update the prior authorization requirement list throughout the year, sometimes without properly informing infusion centers. A drug or code that didn’t require authorization last month may require it now, and a center running on last year’s checklist can be impacted.
Missing Clinical Documentation at Submission
Requests submitted without treatment history, lab values, or proper medical necessity often get denied on technical grounds, and not because the treatment provided was inappropriate.
Coding Mismatches Between Authorization and Claim
An authorization approved for one CPT code or J-code doesn’t cover a slightly different one that is used at the time of the billing, even when the clinical intent seems identical.
Now these aren’t scenarios that occur once in a while. Missing or incomplete prior authorization submissions account for one in five denied claims and industry-wide eligibility errors. These numbers are only going to increase if the entire infusion billing process is not carried out with enhanced accuracy. In fact, Medicare Advantage plans in particular have seen a sharp rise in PA denials this year.
The Shrinking Appeal Window
Even when a denial is winnable on appeal, and the overturn rate on prior authorization appeal is quite high, the window to act on it is becoming shorter with time. The major payers have compressed their standard appeal timelines over the past few years. They have moved from windows measured in weeks down to days. Infusion centers running denial reviews on a weekly or biweekly basis are increasingly missing those details. This can turn recoverable denials into permanent write-offs.
These days, a lot of payers are also incorporating AI assistant tools to review and issue first-pass denials faster than many building teams can respond. This can help speed up the process that used to move at a slower human pace. This is how inclusion centers are trying to overturn denial claims. They are also seeking the help of experts like RCM Workshop to walk them through where exactly their current processes are breaking down and what changes can be made to reduce the claim denial rate.
How to Protect the Revenue Behind the Chair?
The infusion centers holding their denials down mostly follow a few habits:
- Verifying prior authorization requirements before scheduling and not after the patient is already admitted for infusion.
- Starting the re-authorization at least two weeks before the existing authorization expires, especially for the ongoing infusion cycle.
- Submitting the request electronically with proper documentation attached the first time itself rather than relying on fax.
- Tracking authorization status against the actual J-codes and CPT codes that appear on the claim to ensure that there is no mismatch.
- Reviewing the details on a tight cycle that matches the shorter appeal window, which the payers are now reinforcing.
In Conclusion
Infusion centers don’t lose revenue because the infusion was not delivered correctly; they lose it because the authorization behind the infusion was not properly renewed, tracked, or documented with the same discipline as the chair time itself.
Getting ahead of these gaps by treating prior authorization as a part of clinical workflow rather than an administrative afterthought can help infusion centers easily reduce prior authorization errors and bring down the denial rate.
As you can see, your prior authorization isn’t going away, and the process is also not going to get simpler with time. However, the centers that treat it as inseparable from clinical scheduling rather than separate paperwork are the ones that can keep their chair time as billable as it was always meant to be.
Need help with prior auth for infusion billing? Talk with our experts today.
